Market research
VBS.AU Vectus Biosystems Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 10M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.29
Community
Investor discussion
1 comment
Sign in to join the VBS.AU discussion.
5 years, 5 months ago
Vectus Biosystems Limited is currently in a long term uptrend where the price is trading 14.2% above its 200 day moving average.
From a valuation standpoint, the stock is 538.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1644.5.
Vectus Biosystems Limited's total revenue rose by 22759.1% to $50K since the same quarter in the previous year.
Its net income has dropped by 104.9% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 31.3% to $-692K since the same quarter in the previous year.
Based on the above factors, Vectus Biosystems Limited gets an overall score of 3/5.